Academe Learn
CBME Curriculum Preview

Page 24 of 24

OG29.1,OG31.1,OG32.1-2,OG34.6 | Benign Gynaecology — PBL Case

CLINICAL SETTING

Mrs Saroja, a 58-year-old agricultural labourer from a rural district, is brought to the gynaecology outpatient clinic by her daughter. She had her last menstrual period approximately 14 months ago. For the past 3 months, she has noticed vaginal bleeding on two separate occasions — first a brownish spotting lasting 3 days, and now a fresh red bleed lasting 5 days. She delayed seeking care because she assumed the bleeding was a return of her periods. Saroja is a G5P5 woman who delivered all five children vaginally at home, the last delivery 22 years ago. She has been aware of 'something coming down' from her vagina for the last 8 years, which worsens when she carries heavy loads or coughs. She has never been evaluated for this. She reports frequency of micturition and occasional urinary leakage when she coughs. She has no urinary burning, haematuria, or bowel complaints. She is otherwise fit, with no significant medical history, and is not on any medications. On general examination: BMI 28 kg/m2, blood pressure 138/86 mmHg. Abdominal examination is unremarkable. On speculum examination (Sims' speculum, left lateral position), the cervix is seen to protrude 3 cm beyond the vaginal introitus with an associated cystocele and rectocele.

Trigger 1: First contact — the bleeding and prolapse presentation

The attending intern is uncertain: Saroja has both active vaginal bleeding AND a significant uterovaginal prolapse. The intern notes the prolapsed cervix has a contact ulcer (decubitus ulcer, approximately 1.5 cm) on its surface. The intern records the POP-Q Stage as Stage III (most distal point +3 cm beyond hymen).

DISCUSSION POINTS

  • What is the most important diagnosis to exclude first in Mrs Saroja, and why does her clinical story fit the definition that mandates urgent investigation? (Apply the PMB cardinal rule.)
  • How does the contact ulcer on the prolapsed cervix affect your investigation plan? Could this be the source of her bleeding, and is it safe to attribute the bleeding to the ulcer?
  • How would you systematically document her prolapse using POP-Q staging, and what does Stage III mean in terms of the hymenal reference point?
  • Why is DeLancey's Level I support (uterosacral and cardinal ligaments) the primary structure that has failed in Mrs Saroja, and what risk factors in her history explain this?
Click to reveal Trigger 2: Investigations are ordered (discuss previous trigger first!)

Trigger 2: Investigations are ordered

Investigations reveal: Haemoglobin 10.8 g/dL (mild anaemia). Pap smear: no malignant cells, inflammatory changes. Transvaginal ultrasound (performed after gentle reduction of the prolapse): uterus 6 × 4 × 3 cm, endometrial thickness 11 mm, no adnexal mass. Urinalysis: no infection. The gynaecology registrar explains to the intern that despite the contact ulcer and the prolapse, the TVS finding of 11 mm endometrial thickness mandates the next step.

DISCUSSION POINTS

  • What is the TVS endometrial thickness threshold that mandates endometrial tissue sampling in a postmenopausal woman not on HRT? How does Mrs Saroja's result compare to this threshold?
  • What tissue sampling method would you choose and why — pipelle biopsy, hysteroscopy with biopsy, or D&C? What is the sensitivity of pipelle biopsy for endometrial carcinoma?
  • The Pap smear shows no malignant cells. Can a normal Pap smear be used to reassure the patient that she does not have endometrial carcinoma? Explain the reason.
  • Construct an integrated investigation plan that addresses all three active clinical problems simultaneously: PMB, uterovaginal prolapse, and urinary symptoms.
Click to reveal Trigger 3: Histology result and the two-pathway decision (discuss previous trigger first!)

Trigger 3: Histology result and the two-pathway decision

Endometrial biopsy returns: proliferative endometrium, no atypia, no malignancy. The contact ulcer swab shows no malignant cells on cytology. The registrar explains there are now two separate active problems requiring a management plan: (1) the likely cause of PMB — most probably the decubitus ulcer/contact bleeding from the prolapse with a benign endometrium — and (2) the symptomatic Stage III uterovaginal prolapse with urinary symptoms. Saroja asks: 'Can the bleeding stop on its own? Do I need an operation?'

DISCUSSION POINTS

  • The histology is benign and the decubitus ulcer is a plausible source of bleeding. Is it now safe to attribute her PMB entirely to the contact ulcer and discharge her? What follow-up is mandatory?
  • What are the surgical management options for Stage III uterovaginal prolapse in a 58-year-old woman who has completed her family? Compare vaginal hysterectomy with pelvic floor repair versus sacrospinous colpopexy in terms of indication, route, and outcomes.
  • Before planning surgical repair of her prolapse, what single investigation is mandatory and why? What specific finding must be identified and addressed in the same operation to prevent a new, disabling complication post-repair?
  • How would you counsel Mrs Saroja about the risks and benefits of surgery versus conservative management (pessary use)? What factors make pessary use difficult in her social context?
Click to reveal Trigger 4: Surgical decision and menopause counselling (discuss previous trigger first!)

Trigger 4: Surgical decision and menopause counselling

Urodynamic studies reveal occult stress urinary incontinence (SUI), unmasked when the prolapse is reduced. The surgical plan is vaginal hysterectomy + anterior colporrhaphy + posterior colpoperineorrhaphy + a mid-urethral sling (MUS) for occult SUI. Post-operatively on day 3, Saroja asks the ward intern: 'Doctor, my periods stopped over a year ago, I have been getting severe hot flushes and poor sleep for 8 months — can I take some hormone treatment now?'

DISCUSSION POINTS

  • Saroja is now 14 months post-LMP, with confirmed benign endometrial histology and a hysterectomy planned (uterus to be removed). Which type of HRT is appropriate post-hysterectomy, and why is a progestogen component NOT required?
  • List three absolute contraindications to HRT that must be checked before prescribing. Does Saroja's history of PMB (now confirmed benign) constitute a contraindication to HRT?
  • Explain the 'timing hypothesis' for HRT and cardiovascular protection to a colleague who argues that HRT is dangerous and should never be started in a 58-year-old woman.
  • What non-hormonal alternatives are available for her vasomotor symptoms if she later develops a contraindication to HRT?
Click to reveal Trigger 5: Long-term follow-up and health promotion (discuss previous trigger first!)

Trigger 5: Long-term follow-up and health promotion

Six months post-surgery, Mrs Saroja returns to clinic. She is continent, the prolapse repair is intact, and hot flushes have improved on oestrogen-only HRT. She mentions that her 26-year-old daughter has been told by a local health worker that 'women who have many children always get prolapse' and wonders if there is anything her daughter can do to prevent this.

DISCUSSION POINTS

  • Explain primary prevention of uterine prolapse to Saroja using DeLancey's three-level pelvic support framework — which level is most vulnerable during vaginal delivery and how can obstetric practice minimise this damage?
  • What is the role of pelvic floor muscle training (PFMT) as secondary prevention in young women after childbirth? When is PFMT insufficient and surgical intervention required?
  • If Mrs Saroja had been postmenopausal for 5 years and presented with PMB, what would a TVS endometrial thickness of 3 mm imply, and how would management differ from her actual TVS finding of 11 mm?
  • What are the long-term health consequences of untreated oestrogen deficiency in menopause that Mrs Saroja's continued HRT is specifically addressing?

Group Task Assignments

  • As a group, construct a complete management algorithm for a 58-year-old woman with PMB + uterovaginal prolapse, from first contact to long-term follow-up.
  • Role-play the counselling of Mrs Saroja about surgical vs conservative (pessary) options for her prolapse, incorporating her socioeconomic context and concerns about anaesthesia.
  • Create a summary table comparing the three main causes of PMB (atrophic vaginitis, endometrial polyp, endometrial carcinoma) across: frequency, TVS finding, investigation, and management.
  • Debate the following statement: 'In a postmenopausal woman with prolapse, the contact ulcer is a sufficient explanation for bleeding and endometrial sampling is unnecessary.'

Learning Issues

Research these questions and bring your findings to the discussion.

  1. [OG32.2] What is the definition of post-menopausal bleeding, and why does it mandate urgent investigation regardless of any clinically apparent alternative source of bleeding?
  2. [OG32.2] What is the TVS endometrial thickness threshold for biopsy in a postmenopausal woman not on HRT, and what is the sensitivity of pipelle biopsy for endometrial carcinoma?
  3. [OG31.1] Describe DeLancey's three levels of pelvic support and explain which level is primarily damaged in uterine prolapse following multiparity.
  4. [OG31.1] What is the POP-Q staging system, and what does Stage III mean in terms of the hymenal reference point?
  5. [OG31.1] Why are urodynamic studies mandatory before surgical prolapse repair, and what is the consequence of missing occult stress urinary incontinence?
  6. [OG32.1] What is the difference between oestrogen-only HRT and combined HRT, and in which clinical situation is oestrogen-only HRT appropriate and why?
  7. [OG32.1] What are the absolute contraindications to HRT, and how should a history of PMB with confirmed benign histology be handled in the context of HRT prescribing?